Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University Hospital of Cologne clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Germany, France, Spain, Italy and Canada registers with University Hospital of Cologne as lead sponsor. Synced 16 Nov 2026
9Current trials
6Recruiting now
0Drugs in these trials
5Trial registers
At a glance

University Hospital of Cologne is the lead sponsor of 9 current clinical trials in our Germany, France, Spain, Italy and Canada registers. 6 are recruiting patients now. The most common phase is Observational. The most-studied condition is HIV.

ClinicalTrials.gov trials by status

  • Recruiting667%
  • Not yet open333%

Trials by phase

  • Observational667%
  • Not applicable333%
01

Clinical trials sponsored by University Hospital of Cologne

9 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
German Centre for Infection Research HIV Translational Platform
NCT02149004 · ClinicalTrials.gov ↗ · HIV
Observational Recruiting 2015-04 Germany
Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support
NCT07655479 · ClinicalTrials.gov ↗ · Cardiogenic Shock Post Myocardial Infarction
Observational Recruiting 2026-04 Germany
Cologne Cohort of Neutropenic Patients (CoCoNut)
NCT01821456 · ClinicalTrials.gov ↗ · Hematological Malignancies, Cancer, Chemotherapy
Observational Recruiting 1995-01 Germany
Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/or <1500 g Birth Weight
NCT07490912 · ClinicalTrials.gov ↗ · Preterm Infant Development, Preterm Infant Health, Prematurity Complications
Observational Recruiting 2026-03 Germany
Characterization of Antibacterial Antibodies in Patients With Cystic Fibrosis
NCT04700358 · ClinicalTrials.gov ↗ · Pulmonary Cystic Fibrosis, Neutralizing Antibodies
Observational Recruiting 2020-10 Germany
Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)
NCT06911099 · ClinicalTrials.gov ↗ · Atrial Functional Mitral Regurgitation, Mitral Insufficiency
Observational Recruiting 2010-01 Germany, France, Spain, Italy, Canada
Exercise Intervention in Women Diagnosed With Triple-negative Breast Cancer Receiving Oncologic Treatment
NCT06497322 · ClinicalTrials.gov ↗ · Breast Cancer, Triple Negative Breast Cancer
Not applicable Not yet open 2024-09 Germany
External Beam Radiotherapy Combined With Endorectal High-dose-rate Brachytherapy in Elderly and Frail Patients With Rectal Cancer
NCT06729645 · ClinicalTrials.gov ↗ · Rectal Cancer
Not applicable Not yet open 2026-09 Germany
Preoperative Physical Exercise, Nutritional Support, and Psychological Intervention (Multimodal Prehabilitation) to Strengthen Patients' Overall Health and Reduce Postoperative Complications
NCT07389746 · ClinicalTrials.gov ↗ · Cancer Surgery, Prehabilitation
Not applicable Not yet open 2026-07 Germany

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in University Hospital of Cologne trials

19 conditions
HIV1Cardiogenic Shock Post Myocardial Infarction1Hematological Malignancies1Cancer1Chemotherapy1Neutropenia1Breast Cancer1Triple Negative Breast Cancer1Rectal Cancer1Preterm Infant Development1Preterm Infant Health1Prematurity Complications1Premature Birth1Cancer Surgery1Prehabilitation1Pulmonary Cystic Fibrosis1Neutralizing Antibodies1Atrial Functional Mitral Regurgitation1Mitral Insufficiency1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Germany96
Clinical trials in France11
Clinical trials in Spain11
Clinical trials in Italy11
Clinical trials in Canada11

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in HIV

SponsorTrials
ViiV Healthcare2
Johns Hopkins University2
National Institute of Allergy and Infectious Diseases (NIAID)2
Centre Hospitalier Universitaire Saint Pierre2
University of Melbourne1
University of Saskatchewan1

Sponsors with the most current trials registered for this condition.

05

Questions about University Hospital of Cologne trials

How many clinical trials does University Hospital of Cologne sponsor?

University Hospital of Cologne is the lead sponsor of 9 current trials on ClinicalTrials.gov in our Germany, France, Spain, Italy and Canada registers, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.

Are University Hospital of Cologne trials recruiting?

Yes. 6 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.